Lind Global Fund II LP 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 8:11 pm Sale | 2023-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Lind Global Fund II LP | 62,500 6.000% | -20,000 (-24.24%) | Filing |
| 2023-03-03 4:18 pm Purchase | 2023-02-24 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Lind Global Fund II LP | 82,500 9.900% | 82,500 (New Position) | Filing |